| Market Cap | ₹63Cr |
| ROE | 16.62% |
| P/E Ratio(TTM) | 26.06 |
| EPS(TTM) | 2.33 |
| P/B Ratio | 8.64 |
| Dividend Yield | 0.00% |
| Industry P/E | 67.34 |
| Book Value | 7.03 |
| Debt to Equity | 0.26 |
| Face Value | 10 |
| Parent Organisation | Aspira Pathlab & Diagnostics Limited |
| Managing Director | NA |
| BSE Symbol | 540788 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Dr Lal PathLabs | NA (0.00%) | 48.69 | ||
| Metropolis Healthcare | NA (0.00%) | 66.72 | ||
| Vijaya Diagnostic Centre | NA (0.00%) | 67.14 | ||
| Thyrocare Technologies | NA (0.00%) | 58.51 |